COMP <GO>
TRIP vs HSTM // FORWARD P/E MULTIPLE
TripAdvisor Inc. (NASDAQ) VS. HealthStream Inc. (NASDAQ) • 15-METRIC TALLY: TRIP 6
— HSTM 5
▲ FORWARD P/E MULTIPLE LEADER: TRIP
LAST: $9.22 (+3.13%) • MKT CAP: $1.08B
forward-pe
25.1x
LAST: $33.80 (+0.21%) • MKT CAP: $1.03B
forward-pe
52.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRIP VS. HSTM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRIP | HSTM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.00% | 5.00% | +8.00 | TRIP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.5x | 42.7x | -31.20 | TRIP | /valuation <GO> |
| Free Cash Flow Yield | 22.67% | 5.77% | +16.90 | TRIP | /fcf-yield <GO> |
| Operating Margin | 4.20% | 6.70% | -2.50 | HSTM | /operating-margins <GO> |
| Net Profit Margin | 2.10% | 6.00% | -3.90 | HSTM | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | 4.30% | -1.20 | HSTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.36% | -0.36 | HSTM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | TRIP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 61.0 | -9.20 | HSTM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 25.1x | 52.5x | -27.40 | TRIP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.08B | $1.03B | $46.4M | TRIP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRIP REV | HSTM REV | TRIP GROSS % | HSTM GROSS % | TRIP FCF | HSTM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.89B | $304.1M | 92.3% | — | $245.0M | $59.6M |
| FY 2024 | $1.83B | $291.6M | 93.0% | — | $144.0M | $56.3M |
| FY 2023 | $1.79B | $279.1M | — | — | $235.0M | $64.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRIP // BETA —
HSTM // BETA —